CTS Corporation has released an investor presentation highlighting its recent financial performance and strategic initiatives. The company reported last twelve months $(LTM)$ revenue of $541 million and an adjusted EBITDA margin of 23%. CTS continues to diversify its end markets, with 57% of revenue coming from non-transportation sectors, including industrial, aerospace & defense, and medical. The company's global footprint includes operations in America, Europe, and Asia, and its product portfolio spans applications such as medical therapeutics, naval sonar systems, condition monitoring, and electric vehicles. CTS emphasized its focus on technology and operational excellence to support growth and diversification, leveraging its technical and application expertise across multiple sectors. You can access the full presentation through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTS Corporation published the original content used to generate this news brief on February 10, 2026, and is solely responsible for the information contained therein.